Paul Zarogoulidis
- Downregulation of Th 17 response after low dose clarithromycin in non-CF bronchiectasis patientsBy Evangelia Fouka, Ioannis Kotsianidis, George Kolios, Paraskevi Miltiades, Konstantinos I. Arvanitidis, Eirini Filidou, Emmanouil Paraskakis, Paul Zarogoulidis, Eftyxia Kalaitzidou and Demosthenes BourosEvangelia Fouka11st Pulmonary Department, General Hospital G. Papanikolaou, Thessaloniki, GreeceIoannis Kotsianidis2Department of Hematology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, GreeceGeorge Kolios3Laboratory of Pharmacology, Faculty of Medicine, Democritus University of Thrace, Alexandroupolis, GreeceParaskevi Miltiades2Department of Hematology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, GreeceKonstantinos I. Arvanitidis3Laboratory of Pharmacology, Faculty of Medicine, Democritus University of Thrace, Alexandroupolis, GreeceEirini Filidou3Laboratory of Pharmacology, Faculty of Medicine, Democritus University of Thrace, Alexandroupolis, GreeceEmmanouil Paraskakis4Paediatric Department, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, GreecePaul Zarogoulidis5Pulmonary Department, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, GreeceEftyxia Kalaitzidou11st Pulmonary Department, General Hospital G. Papanikolaou, Thessaloniki, GreeceDemosthenes Bouros5Pulmonary Department, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece
- A proposal in small cell lung cancer staging according to TNM systemBy Kostas Zarogoulidis, Dimitris Latsioe, Kostas Porpodis, Paul Zarogoulidis, Nick Antoniou, Ellada Elephteriadou, Efimia Boutsikou, Theodore Kontakiotis and Jan-Paul SculierKostas Zarogoulidis1Pulmonary, Aristotle University, Thessaloniki, GreeceDimitris Latsioe1Pulmonary, Aristotle University, Thessaloniki, GreeceKostas Porpodis1Pulmonary, Aristotle University, Thessaloniki, GreecePaul Zarogoulidis1Pulmonary, Aristotle University, Thessaloniki, GreeceNick Antoniou1Pulmonary, Aristotle University, Thessaloniki, GreeceEllada Elephteriadou1Pulmonary, Aristotle University, Thessaloniki, GreeceEfimia Boutsikou1Pulmonary, Aristotle University, Thessaloniki, GreeceTheodore Kontakiotis1Pulmonary, Aristotle University, Thessaloniki, GreeceJan-Paul Sculier2Oncologie thoracique, Institut Jules Bordet, Bruxelles, Belgium
- The role of second line chemotherapy in small cell lung cancer: A retrospective analysisBy Efimia Boutsikou, Paul Zarogoulidis, Kostas Porpodis, Dimitris Latsios, Maria Kipourou and Kostas ZarogoulidisEfimia Boutsikou1Pulmonary Department, Oncology Unit, G.Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreecePaul Zarogoulidis1Pulmonary Department, Oncology Unit, G.Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceKostas Porpodis1Pulmonary Department, Oncology Unit, G.Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceDimitris Latsios1Pulmonary Department, Oncology Unit, G.Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceMaria Kipourou1Pulmonary Department, Oncology Unit, G.Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceKostas Zarogoulidis1Pulmonary Department, Oncology Unit, G.Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
- DEAE-dextran MMA copolymer non-viral vector for aerosol therapy in respiratory diseasesBy Kaid Darwiche, Paul Zarogoulidis, Christos Ritzoulis, Wolfgang Hohenforst-schmidt, Leonidas Sakkas, Aggeliki Cheva, Antonios Sakkas, Dionysios Spyratos, Dora Sparopoulou and Konstantinos ZarogoulidisKaid Darwiche1University Pulmonary Department-Interventional Unit, ''Ruhrland'' Clinic, University of Duisburg-Essen, Essen, GermanyPaul Zarogoulidis2Pulmonary Department-Oncology Unit, ''G. Papanikolaou'' General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceChristos Ritzoulis3Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, GreeceWolfgang Hohenforst-schmidt4Pulmonary Department, ''Coburg'' Clinic, University of Wuerzburg, Coburg, GermanyLeonidas Sakkas5Pathology Department, ''G. Papanikolaou'' General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceAggeliki Cheva5Pathology Department, ''G. Papanikolaou'' General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceAntonios Sakkas5Pathology Department, ''G. Papanikolaou'' General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceDionysios Spyratos2Pulmonary Department-Oncology Unit, ''G. Papanikolaou'' General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceDora Sparopoulou6Experimental Laboratory, ''Theiageneio'' Anticancer Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceKonstantinos Zarogoulidis2Pulmonary Department-Oncology Unit, ''G. Papanikolaou'' General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
- Comorbitities, responses and survival in pts with NSCLCBy Maria Papaioannou, Efimia Boutsikou, Paul Zarogoulidis, Sofia Lampaki, Kostas Porpodis, Dionisios Spyratos, Ellada Eleftheriadou and Kostas ZarogoulidisMaria Papaioannou1G.Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceEfimia Boutsikou1G.Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreecePaul Zarogoulidis1G.Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceSofia Lampaki1G.Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceKostas Porpodis1G.Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceDionisios Spyratos1G.Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceEllada Eleftheriadou1G.Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceKostas Zarogoulidis1G.Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
- Investigation of gram positive antibiotics as aerosol administration (cubicin, vancomycin, zyvoxid)By Ioannis Kioumis, Paul Zarogoulidis, Sofia Lampaki, John Organtzis, Lonny Yarmus, J. Francis Turner, Konstantinos Zarogoulidis, Georgia Pitsiou, Athanasia Pataka and Robert BrowningIoannis Kioumis1Pulmonary Department, ''G. Papanikolaou'' General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreecePaul Zarogoulidis1Pulmonary Department, ''G. Papanikolaou'' General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceSofia Lampaki1Pulmonary Department, ''G. Papanikolaou'' General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceJohn Organtzis1Pulmonary Department, ''G. Papanikolaou'' General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceLonny Yarmus2Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, GreeceJ. Francis Turner35 Pulmonary Medicine, University of Nevada School of Medicine, National Supercomputing Center for Energy and the Environment University of Nevada, Las Vegas,Konstantinos Zarogoulidis1Pulmonary Department, ''G. Papanikolaou'' General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceGeorgia Pitsiou1Pulmonary Department, ''G. Papanikolaou'' General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceAthanasia Pataka1Pulmonary Department, ''G. Papanikolaou'' General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceRobert Browning4Pulmonary & Critical Care Medicine, Interventional Pulmonology, National Naval Medical Center, Walter Reed Army Medical Center, Bethesda,
- Sleep habits among Greek university studentsBy Athanasia Pataka, Evdokia Sourla, Petros Anagnostopoulos, Georgia Vareta, Nikiforia Aggeli, Prodromos Koutoukoglou, Emmanouil Biolakis, Souzanna Xida, Eleni Vaitsi, Asimina Paspala, Paul Zarogoulidis, Sofia Akritidou and Paraskevi ArgyropoulouAthanasia Pataka1Respiratory Fasilure Unit, G Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceEvdokia Sourla1Respiratory Fasilure Unit, G Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreecePetros Anagnostopoulos2Medical School, Aristotle University of Thessaloniki, Thessaloniki, GreeceGeorgia Vareta2Medical School, Aristotle University of Thessaloniki, Thessaloniki, GreeceNikiforia Aggeli2Medical School, Aristotle University of Thessaloniki, Thessaloniki, GreeceProdromos Koutoukoglou2Medical School, Aristotle University of Thessaloniki, Thessaloniki, GreeceEmmanouil Biolakis2Medical School, Aristotle University of Thessaloniki, Thessaloniki, GreeceSouzanna Xida2Medical School, Aristotle University of Thessaloniki, Thessaloniki, GreeceEleni Vaitsi1Respiratory Fasilure Unit, G Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceAsimina Paspala1Respiratory Fasilure Unit, G Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreecePaul Zarogoulidis3Respiratory Medicine Department, Aristotle University of Thessaloniki, Thessaloniki, GreeceSofia Akritidou1Respiratory Fasilure Unit, G Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceParaskevi Argyropoulou1Respiratory Fasilure Unit, G Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
- Impact on survival of history of diabetus mellitus in NSCLC patientsBy Sofia Lampaki, Efimia Boutsikou, Paul Zarogoulidis, Ellada Eleptheriadou, Dionisis Spyratos and Konstantinos ZarogoulidisSofia LampakiPulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreeceEfimia BoutsikouPulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreecePaul ZarogoulidisPulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreeceEllada EleptheriadouPulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreeceDionisis SpyratosPulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreeceKonstantinos ZarogoulidisPulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, Greece
- The value of cardiopulmonary exercise testing in sarcoidosisBy Evaggelia Fouka, Paul Zarogoulidis, Ioannis Kioumis, Georgia Pitsiou, Konstantinos Zarogoulidis, Anastasios Kallianos, Aggeliki Rapti and Georgia TrakadaEvaggelia Fouka1Pulmonary, Aristotle University of Thessaloniki, Tyhessaloniki, GreecePaul Zarogoulidis1Pulmonary, Aristotle University of Thessaloniki, Tyhessaloniki, GreeceIoannis Kioumis1Pulmonary, Aristotle University of Thessaloniki, Tyhessaloniki, GreeceGeorgia Pitsiou1Pulmonary, Aristotle University of Thessaloniki, Tyhessaloniki, GreeceKonstantinos Zarogoulidis1Pulmonary, Aristotle University of Thessaloniki, Tyhessaloniki, GreeceAnastasios Kallianos2Pulmonary, 2nd Pulmonary Department of ''Sotiria'' Hospital of Chest Diseases, Athens, GreeceAggeliki Rapti2Pulmonary, 2nd Pulmonary Department of ''Sotiria'' Hospital of Chest Diseases, Athens, GreeceGeorgia Trakada3Pulmonary, Alexandra Hospital of Chest Diseases, Athens, Greece
- Cox-2 inhibitors in the treatment of small cell lung cancer patientsBy Efimia Boutsikou, Paul Zarogoulidis, Tania Konstanta, Sofia Lampaki, Lefteris Vlogiaris, Dionisis Spyratos and Konstantinos ZarogoulidisEfimia BoutsikouPulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreecePaul ZarogoulidisPulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreeceTania KonstantaPulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreeceSofia LampakiPulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreeceLefteris VlogiarisPulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreeceDionisis SpyratosPulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreeceKonstantinos ZarogoulidisPulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, Greece
- Neutrophils and spirometry changes in COPD patients treated with roflumilastBy Kalliopi Domvri, Konstantinos Porpodis, Antonis Papaioannou, Paul Zarogoulidis, Dimitrios Dimitrios Petridis, Olga Hatzizisi, Alexandra Liaka, Violeta Kikidaki, Sofia Lampaki, Ioannis Organtzis and Konstantinos ZarogoulidisKalliopi Domvri1Pulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreeceKonstantinos Porpodis1Pulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreeceAntonis Papaioannou1Pulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreecePaul Zarogoulidis1Pulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreeceDimitrios Dimitrios Petridis2Department of Food Technology, School of Food Technology and Nutrition, Alexander Technological Educational Institute, Thessaloniki, GreeceOlga Hatzizisi3Immunology and Histocompatibility Lab, ''G. Papanikolaou'' General Hospital, Thessaloniki, GreeceAlexandra Liaka3Immunology and Histocompatibility Lab, ''G. Papanikolaou'' General Hospital, Thessaloniki, GreeceVioleta Kikidaki3Immunology and Histocompatibility Lab, ''G. Papanikolaou'' General Hospital, Thessaloniki, GreeceSofia Lampaki1Pulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreeceIoannis Organtzis1Pulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, GreeceKonstantinos Zarogoulidis1Pulmonary Department-Oncology Unit, Aristotle University of Thessaloniki, Thessaloniki, Greece
- Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patientsBy Filiz Oezkan, Amir Khan, Paul Zarogoulidis, Wolfgang Hohenforst-Schmidt, Kazuhiro Yasufuku, Takahiro Nakajima, Ruediger Karpf-Wissel, Diana Hartmann, Dirk Theegarten, Lutz Freitag and Kaid DarwicheFiliz Oezkan1Department of Interventional Pneumology, Ruhrlandklinik, West German Lung Centre, University Hospital, University Duisburg-Essen, Essen, NRW GermanyAmir Khan2Division of Interventional Pulmonary, Baylor Scott and White Hospital, Waxahachie, TX United StatesPaul Zarogoulidis3Pulmonary Department-Oncology Unit, "G Papanikolaou" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceWolfgang Hohenforst-Schmidt4II Medical Clinic, Coburg Hospital, University of Wuerzburg, Coburg, GermanyKazuhiro Yasufuku5Division of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, CanadaTakahiro Nakajima6Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, JapanRuediger Karpf-Wissel1Department of Interventional Pneumology, Ruhrlandklinik, West German Lung Centre, University Hospital, University Duisburg-Essen, Essen, NRW GermanyDiana Hartmann1Department of Interventional Pneumology, Ruhrlandklinik, West German Lung Centre, University Hospital, University Duisburg-Essen, Essen, NRW GermanyDirk Theegarten7Institute of Pathology, University Hospital of Essen, University Duisburg-Essen, Essen, NRW GermanyLutz Freitag1Department of Interventional Pneumology, Ruhrlandklinik, West German Lung Centre, University Hospital, University Duisburg-Essen, Essen, NRW GermanyKaid Darwiche1Department of Interventional Pneumology, Ruhrlandklinik, West German Lung Centre, University Hospital, University Duisburg-Essen, Essen, NRW Germany
- Gene therapy with DDMC-p53 with or without cisplatin and microwave ablation. A future concept for local treatment in lung cancerBy Paul Zarogoulidis, Wolfgang Hohenforst-Schmidt, Kaid Darwiche, Lutz Freitag, Konstantinos Zarogoulidis, Lonny Yarmus, J. Francis Turner, Robert Browning, Joshua Stopek, Harald Rittger and Thomas VoglPaul Zarogoulidis1Pulmonary-Oncology Unit, ''G.Papanikolaou'' General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceWolfgang Hohenforst-Schmidt2Medical Clinic I, ''Fuerth'' Hospital, University of Erlangen, Fuerth'', GermanyKaid Darwiche3Interventional Pneumology, Ruhrlandklinik, University Hospital Essen, Essen, GermanyLutz Freitag3Interventional Pneumology, Ruhrlandklinik, University Hospital Essen, Essen, GermanyKonstantinos Zarogoulidis1Pulmonary-Oncology Unit, ''G.Papanikolaou'' General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceLonny Yarmus4Division of Pulmonary and Critical Care Medicine, Sheikh Zayed Cardiovascular & Critical Care Tower, Baltimore, United StatesJ. Francis Turner5Division of Interventional Pulmonology & 2 Medical Oncology, Cancer Treatment Centers of America, Western Regional Medical Center, Goodyear, AZ United StatesRobert Browning6Pulmonary & Critical Care Medicine, Interventional Pulmonology, National Naval Medical Center, Walter Reed Army Medical Center, Bethesda, United StatesJoshua Stopek7Covidien, Covidien, Texas, United StatesHarald Rittger2Medical Clinic I, ''Fuerth'' Hospital, University of Erlangen, Fuerth'', GermanyThomas Vogl8Department of Diagnostic and Interventional Radiology, Goethe University of Frankfurt, Frankfurt, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.